Daniel Faensen

Daniel Faensen

Auto-generated profile, based on publicly available information

Daniel Faensen

Freie Universität Berlin

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2007 in Emerging Infectious Diseases
Verified
Journal Article
Open access
GKGérard Krause
Gérard Krause
DADoris Altmann
Doris Altmann
DFDaniel Faensen
Daniel Faensen
KPKlaudia Porten
Klaudia Porten
JBJustus Benzler
Justus Benzler
HCHermann Claus
Hermann Claus
In 2001, the Robert Koch Institute (RKI) implemented a new electronic surveillance system (SurvNet) for infectious disease outbreaks in Germany. SurvNet has captured 30,578 outbreak reports in 2001–2005. The size of the outbreaks ranged from 2 to 527 cases. For outbreaks reported in 2002–2005, the median duration from notification of the first case to the local health department until receipt of the outbreak report at RKI was 7 days. Median outbreak duration ranged from 1 day (caused by Campylobacter) up to 73 days (caused by Mycobacterium tuberculosis). The most common settings among the 10,008 entries for 9,946 outbreaks in 2004 and 2005 were households (5,262; 53%), nursing homes (1,218; 12%), and hospitals (1,248; 12%). SurvNet may be a useful tool for other outbreak surveillance systems because it minimizes the workload of local health departments and captures outbreaks even when causative pathogens have not yet been identified.

1 July 1999 in International Journal of Insect Morphology and Embryology
Verified
Journal Article
Closed access
WBWolfgang Blenau
Wolfgang Blenau
MSManfred Schmidt
Manfred Schmidt
DFDaniel Faensen
Daniel Faensen
FSFriedrich-Wilhelm Schürmann
Friedrich-Wilhelm Schürmann

18 July 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HUHelmut Uphoff
Helmut Uphoff
MHMatthias an der Heiden
Matthias an der Heiden
BSBrunhilde Schweiger
Brunhilde Schweiger
HCHartmut Campe
Hartmut Campe
DBDietmar Beier
Dietmar Beier
UBUdo Buchholz
Udo Buchholz
During the autumn wave of the pandemic influenza virus A/(H1N1) 2009 (pIV) the German population was offered an AS03-adjuvanted vaccine. The authors compared results of two methods calculating the effectiveness of the vaccine (VE). The test-negative case-control method used data from virologic surveillance including influenza-positive and negative patients. An innovative case-series methodology explored data from all nationally reported laboratory-confirmed influenza cases. The proportion of reported cases occurring in vaccinees during an assumed unprotected phase after vaccination was compared with that occurring in vaccinees during their assumed protected phase. The test-negative case-control method included 1,749 pIV cases and 2,087 influenza test-negative individuals of whom 6 (0.3%) and 36 (1.7%), respectively, were vaccinated. The case series method included data from 73,280 cases. VE in the two methods was 79% (95% confidence interval (CI) = 35–93%; P = 0.007) and 87% (95% CI = 78–92%; P<0.001) for individuals less than 14 years of age and 70% (95% CI = −45%–94%, P = 0.13) and 74% (95% CI = 64–82%; P<0.001) for individuals above the age of 14. Both methods yielded similar VE in both age groups; and VE for the younger age group seemed to be higher.

6 February 2009 in Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
Verified
Journal Article
Closed access
PDF file
AAAndrea Ammon
Andrea Ammon
DFD. Faensen
D. Faensen

1 January 1998 in Lecture Notes in Computer Science
Verified
Book Chapter
Closed access
PDF file
DFDaniel Faensen
Daniel Faensen
AHAnnika Hinze
Annika Hinze
HSHeinz Schweppe
Heinz Schweppe

1 January 1999 in Lecture Notes in Computer Science
Verified
Book Chapter
Closed access
PDF file
AHAnnika Hinze
Annika Hinze
DFDaniel Faensen
Daniel Faensen